News and updates for Opal Therapeutics and research into reproductive health
-
WPI Journal Cover Story - Opal Therapeutics!
February 6th, 2025
Opal CEO, Morgan Stanton is featured in the WPI Journal and discusses why we need to make major changes in addressing women’s health.
-
Opal hosts Techstars alumni coffee hour at JPM
January 13th, 2025
Join Opal Therapeutics and other health tech Techstar’s alumni for a networking coffee hour at the 2025 JPM Healthcare conference
-
Opal Therapeutics arrives at Techstars Demo Day!
December 6th, 2024
All Opal’s hard work has paid off! See CEO, Morgan Stanton, be the first pitch at Techstars San Franciso Demo Day.
-
Opal participates in WIB Panel on maternal health
November 14, 2024
Opal participated in a Women in Bio panel discussing, “Enhancing mother and child's health” hosted at Natera
-
CEO, Morgan Stanton, nominated for CLS Pantheon Award
November 7th, 2024
Opal CEO, Morgan Stanton, was nominated for the California Life Sciences Inspiring Future Leaders Pantheon Award.
-
Opal Therapeutics joins Techstars 1st San Francisco Cohort
Septemer 9th, 2024
We are thrilled and honored to announce Opal has been accepted into the Techstar’s SF accelerator program!
-
Opal awarded NSF SBIR Grant
August 22, 2024
Opal is proud to annouce they are the recipient of a Phase I NSF SBIR grant for their research into therapeutic development for women’s health